Zogenix, Inc. | Therapeutic Solutions for CNS Disorders and Orphan Disease UCB, a global biopharmaceutical company, has several locations. Global headquarters are in Brussels, Belgium, with U.S. headquarters in Atlanta, Georgia. Additional U.S. sites include global clinical Zogenix is committed to developing and commercializing therapies for central nervous system disorders that address specific clinical needs for people living with orphan diseases and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.